41 – 50 of 238
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
- Contribution to journal › Article
-
Mark
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis : A Multinational Retrospective Study
- Contribution to journal › Article
-
Mark
Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk
- Contribution to journal › Article
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
- Contribution to journal › Article
-
Mark
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019 : a registry-based cohort study
- Contribution to journal › Article
-
Mark
Test–Retest Reliability, Agreement and Criterion Validity of Three Questionnaires for the Assessment of Physical Activity and Sedentary Time in Patients with Myocardial Infarction
- Contribution to journal › Article
-
Mark
Elevated low-density lipoprotein cholesterol : An inverse marker of morbidity and mortality in patients with myocardial infarction
- Contribution to journal › Article
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
(2023) Svensk Förening för Klinisk Fysiologi Höstmöte
- Contribution to conference › Poster
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
(2023) Svensk förening för klinisk fysiologi - Höstmötet 2023
- Contribution to conference › Poster
-
Mark
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
- Contribution to journal › Article
